B
Biofourmis
Biotechnology company that augments personalized care and therapies using digital therapeutics
News
Open roles
Biofourmis in the Boston ecosystem
The Biofourmis office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
- EIEden Strategy Institute
- SPSpesNet Pte.
Series A2 investors entered at this stage
- OVOpenspace Ventures
- AVAviva Ventures
Series B and later10 investors entered at this stage
Sequoia- CHCVS Health
- JCJinke Entertainment Culture
General Atlantic
SoftBank Vision Fund- MVMassMutual Ventures
- EDEDBI
Intel Capital
SoftBank- SGSGInnovate
Source: Dealroom Talent Intelligence.
Investments and acquisitions
Disclosed deals where Biofourmis was the backer or acquirer, 2019–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Biofourmis's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Biofourmis's portfolio, mapped.
See Biofourmis on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
